Perspectives in Medical Research

Volume: 8 Issue: 1

  • Open Access
  • Editorial

Coronavirus Disease (COVID-19)/SARS-CoV-2: Hopefully, the Human-Virus Battle Ends Soon on a Positive Note

Venkataramana Kandi

*Corresponding author
Address for correspondence: Dr. Venkataramana Kandi Associate Professor of Microbiology, Prathima Institute of Medical Sciences, Karimnagar, Telangana, India
E mail ID: - [email protected], [email protected]

Year: 2020, Page: 1-3,

Abstract

The emergence and re-emergence of infectious diseases are not uncommon to humans. We have been seeing this, repeated many a time in the past, that the new/novel microbial species emerge and pose a potential threat to the whole of mankind. Among those infectious diseases which threatened mankind, the Smallpox virus appears to have had the greatest impact. Smallpox virus was suspected to be present on the earth since 10,000 B.C., but its presence and the effect on humans was established only in the late 18th century to the early 20th century when people suffered from its consequences. Most people (>75%) infected with smallpox died, leaving a sense of doom among humans. Later, or probably during the same time, there was the emergence of an infectious disease called “plague”, which swept across many countries and caused a lot of mortality. This disease was also called the black death, due to the nature of lesions caused and the thousands of people who were dying in very less time. We have also seen the emergence of a novel influenza virus, the Spanish flu (1918) which caused a severe pandemic. Interestingly, all these infectious diseases caused pandemics involving several countries, and causing increased mortality, especially in the European continent. In this editorial I discuss the significance of the most recent pandemic caused by the Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV2), also called Coronavirus disease-19 (COVID-19).

Keywords: Severe Acute Respiratory Syndrome-Coronavirus2 (SARS-CoV-2), COVID-19, emergence, re-emergence, infectious diseases, Pandemic

References

1. Pal M, Berhanu G, Desalegn C, Kandi V. Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update. Cureus. 2020;12(3): e7423. Published 2020 Mar 26. doi:10.7759/cureus.7423
2. Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection [published online ahead of print, 2020 Apr 20]. Eur J Intern Med. 2020; S0953-6205(20)30151-5. doi: 10.1016/ j.ejim.2020.04.037
3. McKee DL, Sternberg A, Stange U, Laufer S, Naujokat C. Candidate drugs against SARS-CoV-2 and COVID-19 [published online ahead of print, 2020 Apr 29]. Pharmacol Res. 2020;104859. doi: 10.1016/j.phrs.2020.104859
4. Pal M, Kerorosa GB, Kandi V. Aknowledge update on SARSCoronavirus-2 (SARS-COV-2) / Covid-19 and it’s global public health implications. American Journal of Clinical Medicine Research 2020;8:23-27. doi: 10.12691/ajcmr-8- 1-5

Cite this article

Kandi V. Coronavirus Disease (COVID-19)/SARS-CoV-2: Hopefully, the Human-Virus Battle Ends Soon on a Positive Note. Perspectives in Medical Research 2020; 8(1): 1-3

Views
197
Downloads
80